McDermott Will & Emery LLP acted as legal advisor to BPD on the transaction. BPD, the premier data-driven health system marketing services company in the United...
BPD’s Acquisition of Revive Marketing
Blue Sprig’s Acquisition of Trumpet Behavioral Health
McDermott Will & Emery represented MTS-TBH, LLC in the transaction. MTS-TBH, LLC, a portfolio company of private equity company WindRose Heath Investors, LLC, executed its sale...
Simplicity’s Acquisition of Passerelle Partners
McDermott Will & Emery represented Passerelle Partners in the transaction. Passerelle Partners (Passerelle), a boutique insurance advisory firm, executed its acquisition by Simplicity Group Holdings, Inc....
Gemspring Capital Management’s Acquisition of a Majority Interest in ClearCompany
McDermott Will & Emery represented Gemspring Capital Management, while Winston & Strawn represented ClearCompany in the transaction. Gemspring Capital Management, LLC (Gemspring), a Connecticut-based private equity...
Gemspring Capital Management’s Acquisition of Bradford Soap International
McDermott Will & Emery represented Gemspring Capital Management in the transaction. Gemspring Capital Management, LLC, a Connecticut-based private equity firm (“Gemspring Capital”), announced its platform acquisition...
Option Care Health’s Merger with Amedisys
Kirkland & Ellis and McDermott Will & Emery LLP advised Option Care Health on the transaction while Paul, Weiss, Rifkind, Wharton & Garrison LLP advised Amedysis....
Brown-Forman’s Acquisition of Diplomático Rum
Cuatrecasas advised the US Brown-Forman Corporation on the deal, while McDermott Will & Emery represented Destillers United Group. US Brown-Forman Corporation acquired the companies in the...
Littlejohn & Co.’s Acquisition of Lipari Foods
McDermott Will & Emery represented H.I.G. Capital in the transaction. H.I.G. Capital, a leading global alternative investment firm with $52 billion of equity capital under management,...
Pasithea Therapeutics’ Acquisition of AlloMek Therapeutics
McDermott Will & Emery represented Pasithea Therapeutics Corp. in the transaction. Pasithea Therapeutics Corp., a biotechnology company focused on the discovery, research and development of innovative...
Calendly’s Acquisition of Prelude
McDermott Will & Emery represented Calendly, LLC in the transaction. Calendly, LLC, the leading scheduling automation platform, announced its acquisition of Prelude, a fast-growing recruiting operations...
WindRose Health Investors’ Investment in Third Wave Recovery Systems
McDermott Will & Emery represented WindRose, while Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo represented Third Wave in the transaction. WindRose Health Investors, LLC, a New...
Mullen Automotive’s $148.2 Million Acquisition of a Controlling Interest in Bollinger Motors
McDermott Will & Emery represented Mullen Automotive, Inc. in the transaction. Mullen Automotive, Inc. (NASDAQ: MULN), an emerging electric vehicle (EV) manufacturer, announced its acquisition of a...